These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

517 related items for PubMed ID: 17316677

  • 1. Delayed electrocardiographic changes after percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Guo H, Wang P, Xing Y, Peng F, Jiang J, Yang B, You B, Qiu Y, Lee JD.
    J Electrocardiol; 2007 Oct; 40(4):356.e1-6. PubMed ID: 17316677
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Progressive decrease of outflow gradient and septum thickness after percutaneous alcoholization of the interventricular septum in hypertrophic obstructive cardiomyopathy.
    Airoldi F, Di Mario C, Catanoso A, Dharmadhikari A, Tzifos V, Anzuini A, Carlino M, Briguori C, Montorfano M, Vaghetti M, Tolaro S, Colombo A.
    Ital Heart J; 2000 Mar; 1(3):200-6. PubMed ID: 10806987
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: Acute results and three-year noninvasive follow-up in 18 patients.
    Guo H, Wang J, Chen J, Shan J, Lee JD, Ueda T.
    Can J Cardiol; 2004 Jun; 20(8):779-82. PubMed ID: 15229758
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Comparison of surgical septal myectomy and alcohol septal ablation with cardiac magnetic resonance imaging in patients with hypertrophic obstructive cardiomyopathy.
    Valeti US, Nishimura RA, Holmes DR, Araoz PA, Glockner JF, Breen JF, Ommen SR, Gersh BJ, Tajik AJ, Rihal CS, Schaff HV, Maron BJ.
    J Am Coll Cardiol; 2007 Jan 23; 49(3):350-7. PubMed ID: 17239717
    [Abstract] [Full Text] [Related]

  • 9. Complications of percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy.
    Zhang W, Li Z, Zhang M, Yuan L, Guan R, Hou A, Jin Y, Deng Z.
    Chin Med J (Engl); 2002 Sep 23; 115(9):1283-6. PubMed ID: 12411095
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Delayed injury of autonomic nerve induced by radiofrequency catheter ablation.
    Guo H, Wang P, Xing Y, Peng F, Jiang J, Yang B, You B, Qiu Y, Lee JD.
    J Electrocardiol; 2007 Oct 23; 40(4):355.e1-4. PubMed ID: 17292382
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Cardiac electromechanical mapping in analyzing the mechanism of left ventricular remodeling immediately after percutaneous transluminal septal ablation in patients with hypertrophic obstructive cardiomyopathy.
    Chen SL, Huang J, Ye F, Shan SJ, Zhang JJ, Duan BX, Chen YD.
    Chin Med J (Engl); 2005 Nov 05; 118(21):1779-85. PubMed ID: 16336814
    [Abstract] [Full Text] [Related]

  • 14. Alcohol septal ablation for hypertrophic obstructive cardiomyopathy: Lower alcohol dose reduces size of infarction and has comparable hemodynamic and clinical outcome.
    Veselka J, Procházková S, Duchonová R, Bolomová-Homolová I, Pálenícková J, Tesar D, Cervinka P, Honek T.
    Catheter Cardiovasc Interv; 2004 Oct 05; 63(2):231-5. PubMed ID: 15390343
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Non-pharmacologic therapy of hypertrophic obstructive cardiomyopathy--results of therapy based on percutaneous transluminal septal myocardial ablation compared with results of dual-chamber cardiac pacing].
    Krejcí J, Groch L, Meluzín J, Vykypel T, Halámek J, Vitovec J.
    Vnitr Lek; 2006 Apr 05; 52(4):313-20. PubMed ID: 16755987
    [Abstract] [Full Text] [Related]

  • 17. Percutaneous versus surgical treatment for patients with hypertrophic obstructive cardiomyopathy and enlarged anterior mitral valve leaflets.
    van der Lee C, ten Cate FJ, Geleijnse ML, Kofflard MJ, Pedone C, van Herwerden LA, Biagini E, Vletter WB, Serruys PW.
    Circulation; 2005 Jul 26; 112(4):482-8. PubMed ID: 16027255
    [Abstract] [Full Text] [Related]

  • 18. Percutaneous transluminal septal myocardial ablation in hypertrophic obstructive cardiomyopathy: acute results and 3-month follow-up in 25 patients.
    Seggewiss H, Gleichmann U, Faber L, Fassbender D, Schmidt HK, Strick S.
    J Am Coll Cardiol; 1998 Feb 26; 31(2):252-8. PubMed ID: 9462563
    [Abstract] [Full Text] [Related]

  • 19. [Alcohol concentration in the coronary sinus after transarterial ablation of septal hypertrophy in hypertrophic obstructive cardiomyopathy].
    Klein N, Mende M, Hagendorff A, Neugebauer A, Pfeiffer D.
    Dtsch Med Wochenschr; 2000 May 12; 125(19):579-83. PubMed ID: 11320715
    [Abstract] [Full Text] [Related]

  • 20. Delayed occurrence of complete heart block after ethanol septal ablation for hypertrophic obstructive cardiomyopathy.
    Poyet R, Quilici J, Cuisset T, Bali L, Ansaldi S, Prévost S, Habib G, Bonnet JL.
    Int J Cardiol; 2011 Mar 03; 147(2):e32-4. PubMed ID: 19232758
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.